1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 583 F.Supp.3d
  5. 583 F.Supp.3d 455 (2022)
 

IN RE BYSTOLIC ANTITRUST LITIGATION

No. 20-cv-5735 (LJL). CVS Action (No. 20-cv-10087) Walgreen Action (No. 20-cv-9793).

583 F.Supp.3d 455 (2022)

IN RE BYSTOLIC ANTITRUST LITIGATION. This Document Relates to: All Direct Purchaser Actions All End-Payor Actions.

United States District Court, S.D. New York.

Signed February 2, 2022.

OPINION AND ORDER

This civil antitrust action alleges an illegal scheme to delay competition from generic versions of Bystolic (nebivolol hydrochloride), a prescription medication approved by the U.S. Food and Drug Administration to...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases